BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3309191)

  • 1. GFA protein reactivity in nerve sheath tumors: a polyvalent and monoclonal antibody study.
    Stanton C; Perentes E; Collins VP; Rubinstein LJ
    J Neuropathol Exp Neurol; 1987 Nov; 46(6):634-43. PubMed ID: 3309191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas.
    Johnson MD; Glick AD; Davis BW
    Arch Pathol Lab Med; 1988 Feb; 112(2):155-60. PubMed ID: 2447857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors.
    Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
    Hum Pathol; 1989 Nov; 20(11):1089-96. PubMed ID: 2478442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.
    Kawahara E; Oda Y; Ooi A; Katsuda S; Nakanishi I; Umeda S
    Am J Surg Pathol; 1988 Feb; 12(2):115-20. PubMed ID: 3124642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical recognition of human nerve sheath tumors by anti-Leu 7 (HNK-1) monoclonal antibody.
    Perentes E; Rubinstein LJ
    Acta Neuropathol; 1985; 68(4):319-24. PubMed ID: 2418621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intermediate filament complement of the spectrum of nerve sheath neoplasms.
    Gould VE; Moll R; Moll I; Lee I; Schwechheimer K; Franke WW
    Lab Invest; 1986 Oct; 55(4):463-74. PubMed ID: 3531717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial membrane antigen expression by the perineurium of peripheral nerve and in peripheral nerve tumours.
    Theaker JM; Gatter KC; Puddle J
    Histopathology; 1988 Aug; 13(2):171-9. PubMed ID: 3169685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial fibrillary acidic protein (GFAP) immunoreactivity in peripheral nerve sheath tumors.
    Memoli VA; Brown EF; Gould VE
    Ultrastruct Pathol; 1984; 7(4):269-75. PubMed ID: 6543600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.
    Johnson MD; Kamso-Pratt J; Federspiel CF; Whetsell WO
    Arch Pathol Lab Med; 1989 Nov; 113(11):1263-70. PubMed ID: 2479359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of immunohistochemical methods to the study of central nervous system tumors].
    Rubinstein LJ
    Ann Pathol; 1986; 6(3):157-63. PubMed ID: 3535816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial fibrillary acidic (GFA) protein in vertebrates: immunofluorescence and immunoblotting study with monoclonal and polyclonal antibodies.
    Dahl D; Crosby CJ; Sethi JS; Bignami A
    J Comp Neurol; 1985 Sep; 239(1):75-88. PubMed ID: 3900154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.
    Weiss SW; Langloss JM; Enzinger FM
    Lab Invest; 1983 Sep; 49(3):299-308. PubMed ID: 6310227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masking of epitopes in tissue sections. A study of glial fibrillary acidic (GFA) protein with antisera and monoclonal antibodies.
    Dahl D; Grossi M; Bignami A
    Histochemistry; 1984; 81(6):525-31. PubMed ID: 6084655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
    Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
    Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology of early stages of ENU-induced brain tumors in rats.
    Mennel HD; Simon H
    Exp Pathol; 1985; 28(4):207-14. PubMed ID: 3913606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides.
    Debus E; Weber K; Osborn M
    Differentiation; 1983; 25(2):193-203. PubMed ID: 6198232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human peripheral nerve sheath neoplasm: expression of Schwann cell-related markers and their relation to malignant transformation.
    Yasuda T; Sobue G; Ito T; Doyu M; Sugiura I; Hashizume Y; Kato K
    Muscle Nerve; 1991 Sep; 14(9):812-9. PubMed ID: 1656253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunocytochemical demonstration of calcineurin in human nerve cell tumors. A comparison with neuron-specific enolase and glial fibrillary acidic protein.
    Goto S; Matsukado Y; Mihara Y; Inoue N; Miyamoto E
    Cancer; 1987 Dec; 60(12):2948-57. PubMed ID: 2824021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors.
    Johnson MD; Kamso-Pratt J; Pepinsky RB; Whetsell WO
    Hum Pathol; 1989 Aug; 20(8):772-6. PubMed ID: 2526074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of nerve growth factor receptor in human benign peripheral nerve sheath tumor].
    Yasuda T; Sobue G; Hashizume Y; Mitsuma T; Takahashi A
    Rinsho Shinkeigaku; 1989 Apr; 29(4):411-20. PubMed ID: 2558831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.